Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McIntyre

Showing results (111-120 of 1,324) with videos related to

Pageof 133
Sort By:
Neuropsychiatric Disease and Treatment|March 3, 2021
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive DisorderRoger S McIntyre, Henrik Loft, Michael Cronquist Christensen
Journal of Affective Disorders|January 12, 2011
Depression in the workforce: the intermediary effect of medical comorbidityRoger S McIntyre, Samantha Liauw, Valerie H Taylor
Alimentary Pharmacology & Therapeutics|November 4, 2004
Are patients' sedation preferences at gastroscopy influenced by preceding patients' decisions?A Olithselvan, A S McIntyre, D A Gorard
The Journal of Reproductive Medicine|November 1, 1983
Comparative trial of the contraceptive sponge and diaphragm. A preliminary reportD A Edelman, S C Smith, S McIntyre
The Journal of Clinical Psychiatry|March 6, 2018
Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and ManagementLarry Culpepper, Raymond W Lam, Roger S McIntyre
The Journal of Clinical Psychiatry|January 19, 2018
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and ManagementLarry Culpepper, Raymond W Lam, Roger S McIntyre
Journal of Affective Disorders|June 2, 2025
Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE studyHartej Gill, Roger S McIntyre, Michael Cronquist Christensen
Clinical Schizophrenia & Related Psychoses|October 1, 2010
Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medicationsJeanette M Jerrell, Roger S McIntyre, Avnish Tripathi
Clinical Therapeutics|January 11, 2007
Measurable outcomes in psychiatric disorders: remission as a marker of wellnessRoger S McIntyre, Angelo Fallu, Jakub Z Konarski
The Journal of Clinical Psychiatry|January 10, 2017
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness StudiesJoshua D Rosenblat, Yena Lee, Roger S McIntyre
Pageof 133

Showing results (111-120 of 1,324) with videos related to

Sort By:
Pageof 133
Neuropsychiatric Disease and Treatment|March 3, 2021
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive DisorderRoger S McIntyre, Henrik Loft, Michael Cronquist Christensen
Journal of Affective Disorders|January 12, 2011
Depression in the workforce: the intermediary effect of medical comorbidityRoger S McIntyre, Samantha Liauw, Valerie H Taylor
Alimentary Pharmacology & Therapeutics|November 4, 2004
Are patients' sedation preferences at gastroscopy influenced by preceding patients' decisions?A Olithselvan, A S McIntyre, D A Gorard
The Journal of Reproductive Medicine|November 1, 1983
Comparative trial of the contraceptive sponge and diaphragm. A preliminary reportD A Edelman, S C Smith, S McIntyre
The Journal of Clinical Psychiatry|March 6, 2018
Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and ManagementLarry Culpepper, Raymond W Lam, Roger S McIntyre
The Journal of Clinical Psychiatry|January 19, 2018
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and ManagementLarry Culpepper, Raymond W Lam, Roger S McIntyre
Journal of Affective Disorders|June 2, 2025
Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE studyHartej Gill, Roger S McIntyre, Michael Cronquist Christensen
Clinical Schizophrenia & Related Psychoses|October 1, 2010
Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medicationsJeanette M Jerrell, Roger S McIntyre, Avnish Tripathi
Clinical Therapeutics|January 11, 2007
Measurable outcomes in psychiatric disorders: remission as a marker of wellnessRoger S McIntyre, Angelo Fallu, Jakub Z Konarski
The Journal of Clinical Psychiatry|January 10, 2017
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness StudiesJoshua D Rosenblat, Yena Lee, Roger S McIntyre
Pageof 133